Creators of a revolutionary antiviral technology, Nanoveu (ASX:NVU) continue to expand into the Asia-Pacific with a pair of exclusive distribution agreements for the Malaysian and Thailand markets.
The agreements will see the technology, which consists of an antiviral protective layer imprinted upon clear plastic adhesive or consumer-focussed mobile phone cases, distributed in the regions via Sanyo Trading Company.
Sanyo is a major industrial goods importer and exporter listed on the Tokyo Stock Exchange with extensive reach into both markets.
In Thailand, Sanyo has committed to a minimum of US$1,500,000 in purchases to maintain exclusivity, while in Malaysia Sanyo will seek to make a minimum total purchase of US$720,000 over 12 months.
Commenting on the distribution agreement Sanyo Trading sales director Sandy Yew said:
“The spread of disease is a major focus for many countries, including those in the Asia-Pacific region. We are excited about brining Nanoveu’s Nanoshield products to our customers, partners and distributors as it represents a credible and proven method of stemming the spread of harmful viruses and bacteria.”
Independent assessments of the technology have demonstrated that the Nanoshield product is a highly effective agent for the eradication of viruses.
The technology has been proven to eliminate 99.99% of OC43, a viral strain affecting humans that is also a surrogate for COVID-19, in 30 minutes.
The antiviral protection has also been validated against other bacteria and viruses including e.Coli, Influenza A (subtype H3N2), and coronavirus MHV-A592.
The agreement with Sanyo accelerates Nanoveu’s sales activity, following the completion of first orders earlier this month.
Nanoveu has commenced sales in the USA, UK and Australia as well as Singapore through a distribution agreement with AIBI, a sizable fitness equipment and wellness provider.